| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Nov 25, 2019 | GH Guardant Health, Inc. | Talasaz Amirali | Chairman, President And COO | Sell | 46,934 | $80.19 | $3,763,558.98 | -0.7% | |
| Nov 21, 2019 | MTD Mettler Toledo International Inc/ | Filliol Oliver A71 | President And CEO | Sell | 11,499 | $708.41 | $8,145,967.55 | -4.7% | |
| Nov 21, 2019 | RVTY Revvity, Inc. | Witz Pascale | Director | Sell | 1,043 | $90.67 | $94,568.81 | -29.9% | |
| Nov 21, 2019 | EXAS Exact Sciences Corp | Cole G Bradley | General Manager - Diagnostics | Sell | 28,016 | $80.38 | $2,251,926.08 | -47.5% | |
| Nov 21, 2019 | GH Guardant Health, Inc. | Kaul Samir | Director | Sell | 27,423 | $79.05 | $2,167,788.15 | -48.8% | |
| Nov 21, 2019 | GH Guardant Health, Inc. | Meresman Stanley J75 | Director | Sell | 8,000 | $78.65 | $629,200.00 | -86.0% | |
| Nov 21, 2019 | NEO Neogenomics Inc | Jones Steven C | Director | Sell | 151,230 | $24.34 | $3,680,597.54 | -4.7% | |
| Nov 20, 2019 | MTD Mettler Toledo International Inc/ | Filliol Oliver A71 | President And CEO | Sell | 4,761 | $726.40 | $3,458,406.56 | -3.0% | |
| Nov 20, 2019 | GH Guardant Health, Inc. | Talasaz Amirali | Chairman, President And COO | Sell | 174,219 | $78.85 | $13,738,017.82 | -0.7% | |
| Nov 20, 2019 | GH Guardant Health, Inc. | Talasaz Amirali | Chairman, President And COO | Sell | 1,310 | $79.34 | $103,940.01 | -5.7% | |
| Nov 19, 2019 | NEO Neogenomics Inc | Van Oort Douglas M | Chairman And CEO | Sell | 187,500 | $24.08 | $4,515,000.00 | -100% | |
| Nov 19, 2019 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 100,000 | $1.47 | $146,650.73 | - | |
| Nov 19, 2019 | GH Guardant Health, Inc. | Meresman Stanley J75 | Director | Sell | 10,000 | $77.99 | $779,888.80 | -37.8% | |
| Nov 18, 2019 | GH Guardant Health, Inc. | Bertocci Derek A | Chief Financial Officer | Sell | 25,481 | $79.58 | $2,027,777.65 | -12.2% | |
| Nov 18, 2019 | RDNT Radnet, Inc. | Crues John V | Medical Director | Sell | 20,000 | $18.01 | $360,200.00 | -4.6% | |
| Nov 18, 2019 | VCYT Veracyte, Inc. | Hanna John Walter Jr | Chief Commercial Officer | Sell | 19,571 | $25.18 | $492,787.99 | -23.0% | |
| Nov 18, 2019 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 100,000 | $1.48 | $147,924.95 | - | |
| Nov 15, 2019 | WAT Waters Corp /de/ | Beaudouin Mark T | SVP And General Counsel | Sell | 3,175 | $215.00 | $682,625.00 | -43.7% | |
| Nov 15, 2019 | NEO Neogenomics Inc | Balliet Jennifer | VP And Chief Culture Officer | Sell | 6,833 | $23.45 | $160,233.85 | -23.0% | |
| Nov 15, 2019 | VCYT Veracyte, Inc. | Anderson Bonnie H72 | Chairman And CEO | Sell | 20,000 | $25.06 | $501,124.00 | -16.2% | |
| Nov 15, 2019 | MTD Mettler Toledo International Inc/ | Filliol Oliver A71 | President And CEO | Sell | 17,000 | $722.71 | $12,286,020.32 | -10.9% | |
| Nov 15, 2019 | RDNT Radnet, Inc. | Crues John V | Medical Director | Sell | 20,000 | $17.78 | $355,600.00 | -4.4% | |
| Nov 15, 2019 | AWHL Aspira Women's Health Inc. | Beechey Robert Harry | Chief Financial Officer | Buy | 5,000 | $0.71 | $3,541.50 | +2.4% | |
| Nov 14, 2019 | RDNT Radnet, Inc. | Crues John V | Medical Director | Sell | 20,000 | $15.84 | $316,800.00 | -4.2% | |
| Nov 13, 2019 | IMDX Insight Molecular Diagnostics Inc. | Broadwood Partners, L.P.60 | 10% Owner | Buy | 1,176,471 | $1.70 | $2,000,000.70 | +5.0% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.